awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q38845681-DC556D1E-04F5-417D-BC5A-4DE3A1E86532
Q38845681-DC556D1E-04F5-417D-BC5A-4DE3A1E86532
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38845681-DC556D1E-04F5-417D-BC5A-4DE3A1E86532
miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met.
P2860
Q38845681-DC556D1E-04F5-417D-BC5A-4DE3A1E86532
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38845681-DC556D1E-04F5-417D-BC5A-4DE3A1E86532
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5a83e7bdbab0e78d4e8e67ecd3e81a84e12074a3
P2860
Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement.